Skip to main content
. 2020 Jun 27;7(5):2752–2761. doi: 10.1002/ehf2.12867

Figure 3.

Figure 3

Subgroup analysis for the primary outcome after propensity score matching. ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin‐receptor blocker; BMI, body mass index; BNP, B‐type natriuretic peptide; CI, confidence interval; HR, hazard ratio; LVEF, left ventricular ejection fraction; MRA, mineralocorticoid receptor antagonist.